The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A 12-week treatment with fractional CO2laser for vulvovaginal atrophy: a pilot study
Abstract
OBJECTIVE: This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser in the treatment of vulvovaginal atrophy (VVA) in postmenopausal women. METHODS: VVA symptoms were assessed before and after three applications of laser over 12 weeks in 50 women (age 59.6 ± 5.8 years) dissatisfied with previous local estrogen therapies. Subjective (visual analog scale) and objective (Vaginal Health Index Score, VHIS) measures were used during the study period to assess VVA. Quality of life was measured by using the SF-12. A subjective scale to evaluate the degree of pain related to the laser application and the degree of difficulty to perform the laser procedure was used. RESULTS: Fractional CO2 laser treatment was effective to improve VVA symptoms (vaginal dryness, vaginal burning, vaginal itching, dyspareunia, dysuria; p < 0.001) at 12-week follow-up, as well as the VHIS (13.1 ± 2.5 at baseline vs. 23.1 ± 1.9; p < 0.001). Both physical and mental scores of quality of life were significantly improved in comparison with baseline (p < 0.001). Satisfaction with the laser procedure was reported by 42 women (84%) and a minimal discomfort was experienced at the first laser application, mainly because of the insertion and the movements of the probe. Finally, the technique was very easy to perform in all women starting from the second application at week 4 and no adverse events were recorded during the study period. CONCLUSIONS: A 12-week treatment with the fractional CO2 laser was feasible and induced a significant improvement of VVA symptoms by ameliorating vaginal health in postmenopausal women. Further controlled studies should be performed to confirm the present data and to assess the long-term effects of the laser procedure on vaginal tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction
Bump, R. C., Mattiasson, A., Bø, K., Brubaker, L. P., DeLancey, J. O. L., Klarskov, P., Shull, B. L., & Smith, A. R. B. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70243-0 · Cited by 4,275
Ageing populations: the challenges ahead
Christensen, K., Doblhammer, G., Rau, R., & Vaupel, J. W. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61460-4 · Cited by 3,011
Local oestrogen for vaginal atrophy in postmenopausal women
Lethaby, A., Ayeleke, R. O., & Roberts, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub3 · Cited by 601
(2013) · Menopause · doi:10.1097/gme.0b013e3182a122c2 · Cited by 560
Recommendations for the management of postmenopausal vaginal atrophy
Sturdee, D. W., & Panay, N. (2010) · Climacteric · doi:10.3109/13697137.2010.522875 · Cited by 527
Kingsberg, S. A., Wysocki, S., Magnus, L., & Krychman, M. L. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12190 · Cited by 481
Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey
Nappi, R. E., & Kokot-Kierepa, M. (2012) · Climacteric · doi:10.3109/13697137.2011.647840 · Cited by 407
Self-citationBachmann, G. A., Goldstein, S. R., LIU, J. H., Martens, M. G., Pace, D. T., & Pinkerton, J. V. (2013) · Cited by 339
Prevalence and Impact of Vaginal Symptoms Among Postmenopausal Women
Santoro, N., & Komi, J. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01335.x · Cited by 337
Sadovsky, R., Basson, R., Krychman, M., Morales, A. M., Schover, L., Wang, R., & Incrocci, L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01620.x · Cited by 310
Women's voices in the menopause: Results from an international survey on vaginal atrophy
Nappi, R. E., & Kokot-Kierepa, M. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.08.001 · Cited by 302
Self-citationde Villiers, T. J., Pines, A., Panay, N., Gambacciani, M., Archer, D. F., Baber, R. J., Davis, S. R., Gompel, A. A., Henderson, V. W., Langer, R., et al. (2013) · Climacteric · doi:10.3109/13697137.2013.795683 · Cited by 298
Levine, K. B., Williams, R. E., & Hartmann, K. E. (2008) · Menopause · doi:10.1097/gme.0b013e31815a5168 · Cited by 296
Menopause and sexuality: Prevalence of symptoms and impact on quality of life
Nappi, R. E., & Lachowsky, M. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.021 · Cited by 296
Self-citationImpact of vulvovaginal atrophy on sexual health and quality of life at postmenopause
Nappi, R. E., & Palacios, S. (2014) · Climacteric · doi:10.3109/13697137.2013.871696 · Cited by 286
Self-citationManagement of post-menopausal vaginal atrophy and atrophic vaginitis
Castelo-Branco, C., Cancelo, M. J., Villero, J., Nohales, F., & Juliá, M. D. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.06.014 · Cited by 281
Portman, D. J., Bachmann, G. A., & Simon, J. A. (2013) · Menopause · doi:10.1097/gme.0b013e318279ba64 · Cited by 246
Parish, Nappi, R., Krychman, Kellogg-Spadt, Simon, Goldstein, & Kingsberg, S. (2013) · International Journal of Women's Health · doi:10.2147/ijwh.s44579 · Cited by 234
Self-citationSelf-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative
Pastore, L. M., Carter, R. A., Hulka, B. S., & Wells, E. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.06.019 · Cited by 210
Fractional laser resurfacing for acne scars: a review
Ong, M. W. S., & Bashir, S. J. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10870.x · Cited by 169
Brincat, M., Muscat Baron, Y., & Galea, R. (2005) · Climacteric · doi:10.1080/13697130500118100 · Cited by 160
Nappi, R. E., Kingsberg, S. A., Maamari, R., & Simon, J. A. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12235 · Cited by 142
Self-citationEfficacy and tolerability of local estrogen therapy for urogenital atrophy
Archer, D. F. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a95581 · Cited by 142
Biglia, N., Moggio, G., Peano, E., Sgandurra, P., Ponzone, R., Nappi, R., & Sismondi, P. (2010) · Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01725.x · Cited by 133
Self-citationPalacios, S. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.04.009 · Cited by 130
The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI
Nappi, R. E., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.657589 · Cited by 115
Self-citationNon-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview
Sinha, A. K., & Ewies, A. A. A. (2012) · Climacteric · doi:10.3109/13697137.2012.756466 · Cited by 112
Recognizing and Treating Urogenital Atrophy in Postmenopausal Women
Goldstein, I. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1384 · Cited by 98
Longo, C., Galimberti, M. G., Pace, B. D., Pellacani, G., & Bencini, P. L. (2012) · Lasers in Medical Science · doi:10.1007/s10103-012-1145-9 · Cited by 92
Chin, S. N., Trinkaus, M., Simmons, C. E., Flynn, C., Dranitsaris, G., Bolivar, R., & Clemons, M. J. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.n.020 · Cited by 82
Identifying and Treating Sexual Dysfunction in Postmenopausal Women: The Role of Estrogen
Simon, J. A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2151 · Cited by 77
Calleja‐Agius, J., & Brincat, M. (2009) · Climacteric · doi:10.1080/13697130902814751 · Cited by 77
EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy
REES, M. C. P., Pérez-López, F. R., Ceasu, I., Depypere, H. T., Erel, C. T., Lambrinoudaki, I. V., Schenck-Gustafsson, K. G., Simoncini, T., van der Schouw, Y. T., & Trémollières, F. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.06.009 · Cited by 76
Tierney, E. P., & Hanke, W. C. (2011) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2011.02082.x · Cited by 74
Current Overview of the Management of Urogenital Atrophy in Women with Breast Cancer
Pruthi, S., Simon, J. A., & Early, A. (2011) · The Breast Journal · doi:10.1111/j.1524-4741.2011.01089.x · Cited by 54
Fournier, A., Kernaleguen, C., Panjo, H., Clavel‐Chapelon, F., & Ringa, V. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ecf3ec · Cited by 31
Urogenital consequences in ageing women
Doumouchtsis, S. K., & Chrysanthopoulou, E. L. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.03.007 · Cited by 30
Cited by
Gandhi, J., Chen, A., Dagur, G., Suh, Y., Smith, N., Cali, B., & Khan, S. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.045 · Cited by 437
Zerbinati, N., Serati, M., Origoni, M., Candiani, M., Iannitti, T., Salvatore, S., Marotta, F., & Calligaro, A. (2015) · Lasers in Medical Science · doi:10.1007/s10103-014-1677-2 · Cited by 268
Self-citationRomero-Otero, J., Lauterbach, R., Aversa, A., Serefoglu, E. C., García-Gómez, B., Parnham, A., Skrodzka, M., Krychman, M., Reisman, Y., Corona, G., et al. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.02.013 · Cited by 16
Metadata
- Authors
- Salvatore, S., Nappi, R. E., Zerbinati, N., Calligaro, A., Ferrero, S., Origoni, M., Candiani, M., & Leone Roberti Maggiore, U.
- Venue
- Climacteric
- Publisher
- Informa UK Limited
- Published
- 2014-06-05
- Volume
- 17
- Issue
- 4
- Pages
- 363-369
- ISSN
- 1369-7137 (ISSN-L)
- 1473-0804
- OpenAlex
- W2139011569
- Cited by
- 310
- References
- 38
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.